Reframing the clinical phenotype and management of cryptococcal meningitis.
Maria Francisca RochaHamish D C BainNeil StoneDavid MeyaLucia DarieAhmed K TomaMichael P T LunnArpan R MehtaCharles Hamish CoughlanPublished in: Practical neurology (2024)
Cryptococcal meningitis is an important global health problem, resulting from infection with the yeast Cryptococcus , especially Cryptococcus neoformans and Cryptococcus gattii , which cause a spectrum of disease ranging from pulmonary and skin lesions to life-threatening central nervous system involvement. The diagnosis and management of cryptococcal meningitis have substantially changed in recent years. Cryptococcal meningitis often occurs in people living with advanced HIV infection, though in high-income countries with robust HIV detection and treatment programmes, it increasingly occurs in other groups, notably solid-organ transplant recipients, other immunosuppressed patients and even immunocompetent hosts. This review outlines the clinical presentation, management and prognosis of cryptococcal meningitis, including its salient differences in people living with HIV compared with HIV-negative patients. We discuss the importance of managing raised intracranial pressure and highlight the advantages of improved multidisciplinary team working involving neurologists, infectious disease specialists and neurosurgeons.
Keyphrases
- cerebrospinal fluid
- end stage renal disease
- antiretroviral therapy
- ejection fraction
- newly diagnosed
- global health
- hiv infected
- human immunodeficiency virus
- chronic kidney disease
- hepatitis c virus
- prognostic factors
- pulmonary hypertension
- quality improvement
- physical activity
- mental health
- palliative care
- south africa
- saccharomyces cerevisiae
- combination therapy
- loop mediated isothermal amplification